Adrian Walsh

Nano Biosols Ltd

Bilateral Meetings

  • Thursday (1:30pm – 6:00pm)
  • Friday (9:00am – 12:00pm)
  • Friday (12:00pm – 4:00pm)
DescriptionProducer of nanoparticles for biomedical research and diagnostics.
Nano Biosols Ltd was set up in 2014 with investment from The North West Fund (Biomedical) with a view to capitalising on the founder's experience and helping to develop nanoparticle technology further.

The first generation of biologically functionalised gold nanoparticles was developed as a tool in life science research, mainly in microscopy. The second generation nanoparticles were used as components in lateral flow in-vitro diagnostic kits, where they produce a macroscopic red signal confirming the result of a test. It is predicted that the third generation of gold nanoparticles will feature as theranostics i.e. as therapeutic and diagnostic agents in the developing field of nanomedicine. It is assumed that the next generation will be multi-modal in that they can be targeted, imaged and deliver a therapeutic action.
Organization Type Company
Organization Size1-10
Founding Year2014
CountryUnited Kingdom
CityLiverpool, 131 Mount Pleasant Google map

Technical co-operation

Willing to co-operate with other companies to supply or develop custom nanoparticles for novel applications in nanomedicine. These may include custom nanoparticles for diagnostic kits, in-vivo diagnostic imaging, targetted therapeutics and novel vaccine platforms.

Keywords: nanoparticlesin-vitro diagnosticsnanomedicine

Nanoparticle supply

Supply of custom prepared nanoparticles for diagnostic kits.

Keywords: in vitro diagnosticspoint of care
Cooperation Offered
  1. Technical co-operation
  2. Manufacturing agreement